Compounds > angelicin
Page last updated: 2024-08-21

angelicin and Disease Models, Animal

angelicin has been researched along with Disease Models, Animal in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bai, M; Huang, Q; Li, J; Li, R; Pan, G; Wang, F1
Chen, H; Hu, Y; Li, X; Liao, Y; Lu, W; Song, Z; Xia, X; Yu, C; Zhang, J; Zhou, W1
Chen, N; Deng, YH; Feng, HH; Gao, HY; Li, RS; Liu, F; Soromou, LW; Sun, GQ1

Other Studies

3 other study(ies) available for angelicin and Disease Models, Animal

ArticleYear
Angelicin inhibits liver cancer growth in vitro and in vivo.
    Molecular medicine reports, 2017, Volume: 16, Issue:4

    Topics: Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Caspase 9; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Drug; Furocoumarins; Humans; Liver Neoplasms; Male; Mice; Mitochondria; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Xenograft Model Antitumor Assays

2017
New Application of Psoralen and Angelicin on Periodontitis With Anti-bacterial, Anti-inflammatory, and Osteogenesis Effects.
    Frontiers in cellular and infection microbiology, 2018, Volume: 8

    Topics: Alkaline Phosphatase; Alveolar Bone Loss; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Biofilms; Bone Morphogenetic Proteins; Cell Survival; Core Binding Factor Alpha 1 Subunit; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Ficusin; Furocoumarins; Gene Expression; Homeodomain Proteins; Humans; Inflammation; Interleukin-1beta; Interleukin-8; Lipopolysaccharides; Male; Medicine, Chinese Traditional; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Osteogenesis; Osteopontin; Periodontal Diseases; Periodontal Ligament; Periodontitis; Porphyromonas gingivalis; RNA, Messenger; THP-1 Cells; Transcription Factors; Up-Regulation

2018
Angelicin regulates LPS-induced inflammation via inhibiting MAPK/NF-κB pathways.
    The Journal of surgical research, 2013, Volume: 185, Issue:1

    Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Cell Line; Cell Survival; Disease Models, Animal; Furocoumarins; Interleukin-6; Lipopolysaccharides; Macrophages; Male; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; NF-kappa B; Pneumonia; Tumor Necrosis Factor-alpha

2013